ERBB2 and breast cancer: Shang A. and colleagues reported that ectopic expression of miR-326 had a moderate antiproliferative effect on BC cells; the same finding was reported by Baldisseri’s group (p = 0.058) and was associated with increased ribociclib sensitivity in HER2+ BC cell lines [56,63].